Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas.
Phase of Trial: Phase III
Latest Information Update: 18 Feb 2014
At a glance
- Drugs Temozolomide (Primary)
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Pharmacogenomic; Therapeutic Use
- 18 Feb 2013 New source identified and integrated (Robert H. Lurie Comprehensive Cancer Center, Northwestern University: ECOG-E3F05).
- 07 Dec 2012 New source identified and integrated (Mayo Clinic).
- 11 Jul 2012 Planned end date changed from 1 Mar 2016 to 1 May 2026 as reported by ClinicalTrials.gov.